ACTR-16. Results of the Oparatic Trial: A phase I dose escalation study of olaparib in combination with temozolomide (Tmz) in patients with relapsed glioblastoma (Gbm).
Authors
Chalmers, ACruickshank, G
Dunn, L
Erridge, S
Godfrey, L
Herbert, C
Jefferies, S
Lopez, J
McBain, Catherine A
Pittman, M
Sleigh, R
Watts, C
Webster-Smith, M
Halford, S
Affiliation
University of Glasgow, Glasgow, United KingdomIssue Date
2017-11
Metadata
Show full item recordCitation
ACTR-16. Results of the Oparatic Trial: A phase I dose escalation study of olaparib in combination with temozolomide (Tmz) in patients with relapsed glioblastoma (Gbm). 2017, 19 (suppl_6):vi4 Neuro-OncologyJournal
Neuro-OncologyDOI
10.1093/neuonc/nox168.012Type
Meetings and ProceedingsLanguage
enISSN
1522-85171523-5866
ae974a485f413a2113503eed53cd6c53
10.1093/neuonc/nox168.012